Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
scientific article published on 10 April 2019
Author/s
author: Stefan Aebi, Laura Biganzoli, Theodoros Foukakis, Angelo Di Leo, Patrick Neven, Olivia Pagani, Aron Goldhirsch, Meredith M Regan, Manuela Rabaglio, Karin Ribi, Prudence Francis, Marco Colleoni, Thomas Ruhstaller, Weixiu Luo, Daniel A Vorobiof, Jacquie Chirgwin, Ehtesham A Abdi, Arvid Carlsson, Guy Jerusalem, Vincenzo Lauro, Annelore Barbeaux, Marie-Pascale Graas, Claudio Graiff, SOLE Investigators